Publicaciones en las que colabora con José A. San Román (131)

2023

  1. 3D Virtual modelling, 3D printing and extended reality for planning of implant procedure of short-term and long-term mechanical circulatory support devices and heart transplantation

    Frontiers in Cardiovascular Medicine, Vol. 10

  2. Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 7, pp. 580-588

2022

  1. Selection of the best of 2021 in valvular heart diseases

    REC: CardioClinics, Vol. 57, pp. S48-S53

2021

  1. Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 78, Núm. 21, pp. 2106-2125

  2. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

  3. Infective endocarditis in patients with aortic grafts

    International Journal of Cardiology, Vol. 330, pp. 148-157

  4. Prognostic impact of cardiac surgery in left-sided infective endocarditis according to risk profile

    Heart (British Cardiac Society), Vol. 107, Núm. 24, pp. 1987-1994

2020

  1. Contemporary epidemiology and outcomes in recurrent infective endocarditis

    Heart, Vol. 106, Núm. 8, pp. 596-602

  2. Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics

    Canadian Journal of Cardiology, Vol. 36, Núm. 10, pp. 1624-1632

  3. Predictive model of in-hospital mortality in left-sided infective endocarditis

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 902-909

  4. Secreted Phospholipase A2-IIA Modulates Transdifferentiation of Cardiac Fibroblast through EGFR Transactivation: An Inflammation-Fibrosis Link

    Cells, Vol. 9, Núm. 2

2019

  1. Impact of Valve Culture in the Prognosis of Active Left-sided Infective Endocarditis

    Clinical Infectious Diseases, Vol. 68, Núm. 6, pp. 1017-1023

2018

  1. Comments on the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

    Revista espanola de cardiologia (English ed.), Vol. 71, Núm. 2, pp. 67-73

  2. Comparison of the Hemodynamic Performance of the Balloon-expandable SAPIEN 3 Versus Self-expandable Evolut R Transcatheter Valve: A Case-matched Study

    Revista Espanola de Cardiologia, Vol. 71, Núm. 9, pp. 735-742

  3. Early surgery for acute-onset infective endocarditis

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 54, Núm. 6, pp. 1060-1066

  4. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

  5. The impact of obesity in the cardiac lipidome and its consequences in the cardiac damage observed in obese rats

    Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 1, pp. 10-20

2017

  1. Evolution of Prognosis in Left-Sided Infective Endocarditis: A Propensity Score Analysis of 2 Decades

    Journal of the American College of Cardiology

  2. Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: The AGTP II trial

    BMJ Open, Vol. 7, Núm. 8

  3. Risk score for cardiac surgery in active left-sided infective endocarditis

    Heart, Vol. 103, Núm. 18, pp. 1435-1442